Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:3107-3116

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Kooij, M. A.
Right arrow Articles by Morand, O. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Kooij, M. A.
Right arrow Articles by Morand, O. H.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:3107-3116.)
© 1997 American Heart Association, Inc.


Articles

Human Monocyte–Derived Macrophages Express an {approx}120-kD Ox-LDL Binding Protein With Strong Identity to CD68

Maaike A. van der Kooij; Elisabeth M. von der Mark; J. Kar Kruijt; Agnes van Velzen; Theo J.C. van Berkel; ; Olivier H. Morand

From the Pharma Division, Preclinical Research, Hoffmann–La Roche Ltd, Basel, Switzerland (M.A. van der K., E.M. von der M., O.H.M.), and the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, University of Leiden, Leiden, the Netherlands (M.A. van der K., J.K.K., A. van V., Th.J.C. van B.).

Correspondence to Dr O.H. Morand, c/o Hoffmann–La Roche Ltd, Pharma Division, Preclinical Research, PRPV, B68/R334, Grenzacherstrasse 124, CH-4070 Basel, Switzerland. E-mail olivier.morand{at}roche.com

Abstract A protein that specifically binds oxidized LDL (Ox-LDL) has recently been characterized in mouse peritoneal macrophages and identified as macrosialin, a protein with a molecular weight of 95 kD. First, the present work shows that human monocyte–derived macrophages express a membrane protein with a molecular weight of {approx}120 kD that selectively binds Ox-LDL. Second, we tested whether this {approx}120-kD Ox-LDL binding protein had any relation to CD68, the human homologue of macrosialin. The following evidence was obtained to support the role of CD68 as an Ox-LDL binding protein: (1) Ligand blots with Ox-LDL and Western blots with Ki-M6, an anti–human CD68 monoclonal antibody, revealed a single band with a molecular weight of {approx}120 kD under reducing and nonreducing condition. (2) The expression patterns of the {approx}120-kD Ox-LDL binding membrane protein and of CD68 paralleled each other during monocyte/macrophage differentiation. (3) Digestion with N-glycosidase F demonstrated that both CD68 and the Ox-LDL binding protein are glycoproteins; both showed a similar shift of {approx}18 kD in apparent molecular weight. (4) CD68, probed with monoclonal antibody Ki-M6, and the {approx}120-kD Ox-LDL binding protein were coprecipitated with EBM11, another anti-CD68 antibody. About 5000 molecules of CD68 are expressed on the cell surface of human macrophages. Ligation of 125I–Ki-M6 to cells leads to its internalization and degradation. This capacity would be sufficient to allow for the specific uptake and degradation of Ox-LDL. Taken together, these data support a role for CD68 as a specific Ox-LDL binding protein in human monocyte–derived macrophages.


Key Words: atherosclerosis • macrophages • oxidized LDL • CD68




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
M. C. de Beer, Z. Zhao, N. R. Webb, D. R. van der Westhuyzen, and W. J. S. de Villiers
Lack of a direct role for macrosialin in oxidized LDL metabolism
J. Lipid Res., April 1, 2003; 44(4): 674 - 685.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Mäkitie, P. Summanen, A. Tarkkanen, and T. Kivelä
Tumor-Infiltrating Macrophages (CD68+ Cells) and Prognosis in Malignant Uveal Melanoma
Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1414 - 1421.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. Terpstra, E. S. van Amersfoort, A. G. van Velzen, J. Kuiper, and T. J. C. van Berkel
Hepatic and Extrahepatic Scavenger Receptors : Function in Relation to Disease
Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1860 - 1872.
[Full Text] [PDF]


Home page
CirculationHome page
G. Chinetti, F. G. Gbaguidi, S. Griglio, Z. Mallat, M. Antonucci, P. Poulain, J. Chapman, J.-C. Fruchart, A. Tedgui, J. Najib-Fruchart, et al.
CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors
Circulation, May 23, 2000; 101(20): 2411 - 2417.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M Kostich, A Fire, and D. Fambrough
Identification and molecular-genetic characterization of a LAMP/CD68-like protein from Caenorhabditis elegans
J. Cell Sci., January 7, 2000; 113(14): 2595 - 2606.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Hrboticky, G. Draude, G. Hapfelmeier, R. Lorenz, and P. C. Weber
Lovastatin Decreases the Receptor-Mediated Degradation of Acetylated and Oxidized LDLs in Human Blood Monocytes During the Early Stage of Differentiation Into Macrophages
Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1267 - 1275.
[Abstract] [Full Text] [PDF]